Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical characteristics and outcome of SARS-CoV-2-infected patients with haematological diseases: a retrospective case study in four hospitals in Italy, Spain and the Netherlands.
van Doesum J, Chinea A, Pagliaro M, Pasquini MC, van Meerten T, Bakker M, Ammatuna E. van Doesum J, et al. Among authors: pagliaro m. Leukemia. 2020 Sep;34(9):2536-2538. doi: 10.1038/s41375-020-0960-4. Epub 2020 Jul 8. Leukemia. 2020. PMID: 32641731 Free PMC article. No abstract available.
Massive cerebral venous sinus thrombosis in vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 serum: case report of a successful multidisciplinary approach.
Mirandola L, Arena G, Pagliaro M, Boghi A, Naldi A, Castellano D, Vaccarino A, Silengo D, Aprà F, Cavallo R, Livigni S. Mirandola L, et al. Among authors: pagliaro m. Neurol Sci. 2022 Mar;43(3):1499-1502. doi: 10.1007/s10072-021-05805-y. Epub 2022 Jan 10. Neurol Sci. 2022. PMID: 35001190 Free PMC article.
Italy's excellence in research.
Ciriminna R, Della Pina C, Pagliaro M. Ciriminna R, et al. Among authors: pagliaro m. Heliyon. 2024 Dec 18;11(1):e41335. doi: 10.1016/j.heliyon.2024.e41335. eCollection 2025 Jan 15. Heliyon. 2024. PMID: 39811304 Free PMC article.
Clinical and Market Analysis of NanoBEO: A Public-Worth, Innovative Therapy for Behavioral and Psychological Symptoms of Dementia (BPSD)-Emerging Evidence and Its Implications for a Health Technology Assessment (HTA) and Decision-Making in National Health Systems.
Scuteri D, Pierobon D, Pagliaro M, Hamamura K, Hayashi T, Pignolo L, Nicotera P, Bagetta G, Corasaniti MT. Scuteri D, et al. Among authors: pagliaro m. Pharmaceutics. 2024 Sep 27;16(10):1253. doi: 10.3390/pharmaceutics16101253. Pharmaceutics. 2024. PMID: 39458585 Free PMC article.
Reproducible Green Syntheses Using Hybrid Sol-Gel Catalysts.
Ciriminna R, Luque R, Pagliaro M. Ciriminna R, et al. Among authors: pagliaro m. Chemistry. 2024 Sep 5;30(50):e202402071. doi: 10.1002/chem.202402071. Epub 2024 Aug 20. Chemistry. 2024. PMID: 39162708 Review.
Efficacy of therapeutic intervention with NanoBEO to manage agitation and pain in patients suffering from severe dementia: a pilot clinical trial.
Scuteri D, Pagliaro M, Mantia I, Contrada M, Pignolo L, Tonin P, Nicotera P, Bagetta G, Corasaniti MT; Pilot BRAINAID Trial investigators. Scuteri D, et al. Among authors: pagliaro m. Front Pharmacol. 2024 Aug 1;15:1417851. doi: 10.3389/fphar.2024.1417851. eCollection 2024. Front Pharmacol. 2024. PMID: 39148533 Free PMC article.
145 results